Esophagogastric Junction

• 

  Subject Areas on Research

  • A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. 
  • A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas. 
  • Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). 
  • An Odyssey of complications from band, to sleeve, to bypass; definitive laparoscopic completion gastrectomy with distal esophagectomy and esophagojejunostomy for persistent leak. 
  • Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction. 
  • Barrett's esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet. 
  • CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. 
  • CT of fundoplication. 
  • Caustic ingestion. 
  • Celecoxib (celebrex) increases canine lower esophageal sphincter pressure. 
  • Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in China. 
  • Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure. 
  • Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation. 
  • Computed tomography of the gastroesophageal junction: value of the left lateral decubitus view. 
  • Elevated intrabolus pressure identifies obstructive processes when integrated relaxation pressure is normal on esophageal high-resolution manometry. 
  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Esophageal and esophagogastric junction cancers, version 1.2015. 
  • Esophageal and esophagogastric junction cancers. 
  • Esophagogastric junction contractile integral (EGJ-CI) quantifies changes in EGJ barrier function with surgical intervention. 
  • Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. 
  • Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. 
  • Flow cytometry as a predictive indicator in patients with operable gastric cancer. 
  • Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. 
  • Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. 
  • Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. 
  • Interrogation of esophagogastric junction barrier function using the esophagogastric junction contractile integral: an observational cohort study. 
  • Laparoscopic approaches to symptomatic gastroesophageal reflux. 
  • Pathogenesis and Cells of Origin of Barrett's Esophagus. 
  • Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. 
  • Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. 
  • Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. 
  • Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered? 
  • Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers. 
  • Reply to Moris et al. 
  • Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. 
  • Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. 
  • Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. 
  • Technical considerations in radiation therapy for gastroesophageal junction cancer. 
  • The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. 
  • The Use of Fluorescence Angiography During Laparoscopic Sleeve Gastrectomy. 
  • The Utility of Esophageal Motility Testing in Gastroesophageal Reflux Disease (GERD). 
  • The endoscopic radiofrequency approach to management of GERD. 
  • The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. 
  • Three year's experience with the Stretta procedure: did it really make a difference? 
• 

  Keywords of People

  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics